Table 1 Patient demographics.

From: Tc-99m GSA scintigraphy within the first 3 days after admission as an early predictor of outcome in severe acute liver injury

 

n = 69

Age, median (y)

57.0 ± 16.5 (39.5–68)

Male (%)

31 (44.9%)

Etiology

Autoimmune

14

Drug

7

HBV

11

Other virus

8

Unknown

21

Other

8

Died or underwent liver transplantation, n (%)

16 (23.2%)

Survived without liver transplantation, n (%)

53 (76.8%)

Received liver transplantation, n (%)

6 (8.7%)

AST (U/L)

810 (234–2016)

ALT (U/L)

1076 (396–2133)

Total bilirubin (mg/dL)

10.7 (3.38–18.0)

PT-INR

1.65 (1.45–2.16)

MELD score

10.9 (8.9–12.6)

LHL15

0.826 (0.725–0.876)

HH15

0.768 (0.705–0.817)

  1. Data are presented as n (%) or median (interquartile range [IQR]).
  2. HBV hepatitis B virus, AST aspartate aminotransferase, ALT alanine aminotransferase, PT-INR prothrombin time-international normalized ratio, MELD model for end-stage liver disease, LHL15 hepatic accumulation index calculated by dividing the radioactivity of the liver regions of interest by that of the liver-plus-heart regions of interest at 15 min; HH15, blood clearance index calculated by dividing the radioactivity of the heart regions of interest at 15 min by that at 3 min.
Back to article page